Adjuvant treatment for Stage I seminoma: Why radiotherapy is better than carboplatin

Prahlad H Yathiraj, Krishna Sharan, Donald J Fernandes, MS Vidyasagar

Journal of Cancer Research and Therapeutics 2016 12(4):1216-1219

Adjuvant treatment options for Stage I seminoma include active surveillance, chemotherapy, and radiotherapy. Active surveillance may not be ideal for the average Indian patient. Of the two accepted adjuvant therapy options, namely single-dose carboplatin chemotherapy and radiotherapy to the retroperitoneal nodes, though it intuitively appears more appealing, a deeper review reveals the potential drawbacks of chemotherapy. This article highlights the misconceptions regarding carboplatin and provides reasons for an argument why radiotherapy is better when a patient with Stage I seminoma chooses to undergo adjuvant treatment.

http://ift.tt/2kFPUo4